Reference
Sher DJ, et al. Cost-effectiveness Analysis of SBRT Versus IMRT for Low-risk Prostate Cancer. American Journal of Clinical Oncology : 27 Dec 2012. Available from: URL: http://dx.doi.org/10.1097/COC.0b013e31827a7d2a
Rights and permissions
About this article
Cite this article
Most efficient radiotherapy in low-risk prostate cancer?. PharmacoEcon Outcomes News 670, 6 (2013). https://doi.org/10.1007/s40274-013-0093-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0093-3